SOURCE: Vista Partners LLC

Vista Partners LLC

March 07, 2014 09:00 ET

Vista Partners Publishes March 2014 Macroeconomic & Investment Newsletter

Topics Include: Monthly Macroeconomic Commentary, Investment Considerations, Adtech, Biotechnology, Travel, Energy, Healthcare, Natural Resources & More

SAN FRANCISCO, CA--(Marketwired - Mar 7, 2014) - Vista Partners ("Vista") announced today that it published its FREE Macroeconomic & Investment Monthly Newsletter for the month of March. Each monthly newsletter from Vista contains macroeconomic thoughts from Principal Analyst Ross Silver, investment considerations, monthly highlights of each covered company and other broad based commentary.

In the March 2014 Macroeconomic & Investment Newsletter, Mr. Silver states, "Over the past month, I have been asked by both institutional and individual investors my thoughts on whether or not global central bankers have convinced investors (and themselves) that their policies can recreate a semblance of the old 'normal' economy. I provide my thoughts in our free March Newsletter." Mr. Silver concludes, "The outperformance in 2013 has carried over into 2014, as many of the companies we cover have seen their share price increase significantly already in 2014. Cytosorbents Corporation (OTCBB: CTSO) share price has doubled, Mast Therapeutics, Inc. (NYSE MKT: MSTX) and Ohr Pharmaceutical, Inc. (NASDAQ: OHRP) are both up approximately 85% and Accelerize New Media, Inc. (OTCBB: ACLZ) is up 20%."

To read more, please download the FREE March 2014 Macroeconomic & Investment Newsletter available at http://www.vistapglobal.com and click "Download Research & Newsletter" to gain access.

The Companies featured in the FREE March 2014 Newsletter are: Adriana Resources, Inc., Accelerize New Media, Inc., Cytosorbents Corporation, Mast Therapeutics, Inc., Ohr Pharmaceutical, Inc., Soligenix, Inc., Targeted Medical Pharma Inc., Uranerz Energy Corp and Power Solutions International Inc. Other companies mentioned are General Motors, Roche, Novartis, Selexys, Regeneron, Pfizer, Aramark, OpthoTech Corporation and others.

About Vista Partners:
Vista Partners LLC, founded in 2005, is a Registered Investment Advisor in the States of California and Oregon. The firm's professional staff has backgrounds in finance, corporate communications and investment banking. Vista focuses on investing in and providing investment considerations on publicly traded companies through a platform of stock research reports, newsletters, company specific webpages and daily commentary. The platform of products is meant to serve as potential tools for investors to learn about investment considerations. It is Vista's mission to provide investors with tools that may enable them to make profitable investment decisions with the goal to deliver investment considerations that outperform small, mid and large cap equity indexes. Website: http://www.vistapglobal.com

Please follow us on Twitter @VistaPResearch & Facebook at Vista-Partners to receive updates, thoughts and ideas about and our coverage universe of companies and more.

Disclaimer & Disclosure:
We encourage readers to view a complete list of disclaimers and disclosures on our website: www.vistapglobal.com.

Contact Information